ALLO-647
ALLO-647-201
Phase 2 mab terminated
Quick answer
ALLO-647 for Relapsed/Refractory Large B Cell Lymphoma is a Phase 2 program (mab) at Allogene Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Allogene Therapeutics
- Indication
- Relapsed/Refractory Large B Cell Lymphoma
- Phase
- Phase 2
- Modality
- mab
- Status
- terminated